Microfracture is more cost-effective than autologous chondrocyte implantation: a review of level 1 and level 2 studies with 5 year follow-up
- PMID: 29128878
- PMCID: PMC5876257
- DOI: 10.1007/s00167-017-4802-5
Microfracture is more cost-effective than autologous chondrocyte implantation: a review of level 1 and level 2 studies with 5 year follow-up
Abstract
Purpose: Focal cartilage defects in the knee may have devastating effect on the knee joint, where two of the main surgical treatment options are microfracture and autologous chondrocyte implantation. Comparative studies have failed to establish which method yields the best clinical results. A cost-effectiveness analysis of microfracture and autologous chondrocyte implantation would contribute to the clinical decision process.
Methods: A PubMed search identifying level I and level II studies with 5 year follow-up was performed. With the data from these studies, decision trees with associated service provision and costs connected to the two different techniques were designed. In addition to hospital costs, we included costs connected to physiotherapy following surgery. To paint a broader cost picture, we also included indirect costs to the society due to productivity loss caused by work absence.
Results: Four high-quality studies, with a follow-up of 5 years, met the inclusion criteria. A total of 319 patients were included, 170 undergoing microfracture and 149 autologous chondrocyte implantation. The re-operation rate was 23 (13.5%) following microfracture, and 18 (12.1%) for autologous chondrocyte implantation. Both groups achieved substantially better clinical scores at 5 years compared to baseline. Microfracture was more cost-effective when comparing all clinical scores.
Conclusion: Microfracture is associated with both lower costs and lower cost per point increase in patient reported outcome measures. There is a need of well-designed, high-quality randomized controlled trials before reliable conclusions regarding cost-effectiveness in the long run is possible.
Level of evidence: III.
Keywords: Articular cartilage lesion; Autologous chondrocyte implantation; Cost-effectiveness; Microfracture.
Conflict of interest statement
Conflict of interest
The authors declare that they have no competing interests.
Funding
Funded by research grants from the Norwegian Research Council, awarded the Norwegian Cartilage Project (NCP), Grant No. 2015107.
Ethical approval
The manuscript uses clinical data based on previous published literature, all approved by an ethics committee. This study is in accordance with the ethical standards of the 1964 Declaration of Helsinki.
Figures



Similar articles
-
Is implantation of autologous chondrocytes superior to microfracture for articular-cartilage defects of the knee? A systematic review of 5-year follow-up data.Int J Surg. 2019 Aug;68:56-62. doi: 10.1016/j.ijsu.2019.06.007. Epub 2019 Jun 18. Int J Surg. 2019. PMID: 31220632
-
Characterized chondrocyte implantation results in better structural repair when treating symptomatic cartilage defects of the knee in a randomized controlled trial versus microfracture.Am J Sports Med. 2008 Feb;36(2):235-46. doi: 10.1177/0363546507311095. Am J Sports Med. 2008. PMID: 18202295 Clinical Trial.
-
Microfracture Versus Autologous Chondrocyte Implantation for Articular Cartilage Lesions in the Knee: A Systematic Review of 5-Year Outcomes.Am J Sports Med. 2018 Mar;46(4):995-999. doi: 10.1177/0363546517701912. Epub 2017 Apr 19. Am J Sports Med. 2018. PMID: 28423287
-
Microfracture and osteochondral autograft transplantation are cost-effective treatments for articular cartilage lesions of the distal femur.Am J Sports Med. 2015 Sep;43(9):2175-81. doi: 10.1177/0363546515591261. Epub 2015 Jul 9. Am J Sports Med. 2015. PMID: 26159823
-
Arthroscopic second-generation autologous chondrocyte implantation compared with microfracture for chondral lesions of the knee: prospective nonrandomized study at 5 years.Am J Sports Med. 2009 Jan;37(1):33-41. doi: 10.1177/0363546508323256. Epub 2008 Dec 4. Am J Sports Med. 2009. PMID: 19059899
Cited by
-
Matrix-Augmented Bone Marrow Stimulation With a Polyglycolic Acid Membrane With Hyaluronan vs Microfracture in Local Cartilage Defects of the Femoral Condyles: A Multicenter Randomized Controlled Trial.Orthop J Sports Med. 2020 May 29;8(5):2325967120922938. doi: 10.1177/2325967120922938. eCollection 2020 May. Orthop J Sports Med. 2020. PMID: 32528994 Free PMC article.
-
Combination of a human articular cartilage-derived extracellular matrix scaffold and microfracture techniques for cartilage regeneration: A proof of concept in a sheep model.J Orthop Translat. 2023 Dec 30;44:72-87. doi: 10.1016/j.jot.2023.09.004. eCollection 2024 Jan. J Orthop Translat. 2023. PMID: 38259590 Free PMC article.
-
Promoting endogenous articular cartilage regeneration using extracellular matrix scaffolds.Mater Today Bio. 2022 Jul 5;16:100343. doi: 10.1016/j.mtbio.2022.100343. eCollection 2022 Dec. Mater Today Bio. 2022. PMID: 35865410 Free PMC article.
-
Emerging therapies for cartilage regeneration in currently excluded 'red knee' populations.NPJ Regen Med. 2019 May 30;4:12. doi: 10.1038/s41536-019-0074-7. eCollection 2019. NPJ Regen Med. 2019. PMID: 31231546 Free PMC article. Review.
-
Implementation of Endogenous and Exogenous Mesenchymal Progenitor Cells for Skeletal Tissue Regeneration and Repair.Bioengineering (Basel). 2020 Aug 4;7(3):86. doi: 10.3390/bioengineering7030086. Bioengineering (Basel). 2020. PMID: 32759659 Free PMC article. Review.
References
-
- Heir S, Nerhus TK, Røtterud JH, Løken S, Ekeland A, Engebretsen L, Arøen A. Focal cartilage defects in the knee impair quality of life as much as severe osteoarthritis: a comparison of knee injury and osteoarthritis outcome score in 4 patient categories scheduled for knee surgery. Am J Sports Med. 2010;38:231–237. doi: 10.1177/0363546509352157. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous